
Release date: 2026-05-11 11:57:56 Article From: Lucius Laos Recommended: 14
Type 2 diabetes is a condition in which the body does not produce enough insulin, or the insulin produced does not effectively lower blood sugar. In some cases, the body may even produce too much glucose. If blood sugar remains high for a long period, it may lead to serious complications such as heart problems, kidney disease, eye disorders, and poor blood circulation in the limbs. Therefore, it is essential to keep blood glucose within the normal range. Semaglutide is indicated for adult patients (aged 18 years and older) when diet adjustment and exercise are not sufficient to control blood glucose. It can be used alone (especially in patients who cannot take metformin) or in combination with other oral antidiabetic drugs or injectable medications such as insulin to further improve glycemic control. During treatment with this medicine, patients must continue to follow the diet and exercise plan prescribed by their doctor or dietitian to achieve the best therapeutic outcomes.
Semaglutide is contraindicated in the following situations: allergy to semaglutide or any other ingredients in the product (such as sodium salicylate, povidone, microcrystalline cellulose, magnesium stearate, etc.). Furthermore, this medicine is not insulin and therefore cannot be used in patients with type 1 diabetes, nor in cases of diabetes-related acidosis (i.e., diabetic ketoacidosis). The latter is a diabetic emergency characterized by high blood sugar, difficulty breathing, confusion, extreme thirst, sweet-smelling breath, or a metallic taste in the mouth. If you are scheduled for surgery requiring general anesthesia, you should inform your doctor that you are taking Semaglutide. For children and adolescents under 18 years of age, the safety and efficacy of this medicine have not been established, so its use is not recommended. Pregnant or breastfeeding women should not take this medicine. Women planning to become pregnant should stop taking it at least two months in advance and consult their doctor to adjust their treatment regimen.
Semaglutide is an oral tablet whose active ingredient is semaglutide. It is used primarily to lower blood glucose levels in adult patients with type 2 diabetes. Each tablet is available in strengths of 3 mg, 7 mg, and 14 mg.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:3212025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:5312024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:3152025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:3312025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:3062025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3602025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3022025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2812025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: